New research published in Nature Reviews Neurology reveals that dementia will become the world’s third leading cause of death by 2040, surpassed only by ischaemic heart disease and stroke, yet continues to be overlooked in major health policy frameworks and resource allocation.
New research reveals how obesity impairs the function of crucial regulatory T cells in fatty tissue by disrupting their cholesterol metabolism, potentially opening new therapeutic avenues for treating obesity-related metabolic disorders.
Vanderbilt researchers demonstrate effectiveness of automated alerts in prompting suicide risk screening, with interruptive alerts proving significantly more successful than passive notifications.
Novel stimulation protocol helps reduce muscle spasticity and improve walking rehabilitation in patients with incomplete spinal cord injuries, offering hope for enhanced recovery outcomes.
A multi-institutional team has developed a comprehensive suite of machine learning models that can accurately classify cancer samples into molecular subtypes, bridging a critical gap between genomic research discoveries and clinical implementation.
Healthcare technology leader sets ambitious targets for patient reach and environmental impact while achieving workforce diversity milestone ahead of schedule.
The first comprehensive US diagnostic guidelines in two decades establish standardised evaluation process across primary and specialty care settings, emphasising a patient-centred approach and integration of emerging biomarkers.
New research from CUNY identifies how brain immune cells drive neurodegeneration through stress-induced toxic lipid production, offering potential therapeutic targets.
New research suggests that reducing mandatory hand hygiene observations from 200 to 50 per unit monthly would maintain data quality while freeing resources for targeted infection prevention initiatives.
A European research initiative has made significant progress in identifying new treatments to protect heart muscle during acute cardiac events, with potential implications for both diabetic and non-diabetic patients.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
Anna Flury